351003-46-8 Usage
Uses
Used in Pharmaceutical Industry:
3-BROMO-5-(TRIFLUOROMETHYL)BENZENESULFONYL CHLORIDE is used as a key intermediate for the synthesis of various pharmaceuticals. Its unique structure and reactivity allow for the creation of a wide range of biologically active compounds, contributing to the development of new medications.
Used in Agrochemical Industry:
In the agrochemical sector, 3-BROMO-5-(TRIFLUOROMETHYL)BENZENESULFONYL CHLORIDE is utilized as a building block in the production of agrochemicals. Its role in synthesizing compounds with pesticidal properties helps in enhancing crop protection and yield.
Used in Specialty Chemicals:
3-BROMO-5-(TRIFLUOROMETHYL)BENZENESULFONYL CHLORIDE is employed as a versatile intermediate in the synthesis of specialty chemicals, including dyes and other complex organic compounds. Its ability to participate in various chemical reactions makes it indispensable for creating unique and high-value products.
Used in Organic Synthesis:
As a highly electrophilic reagent, 3-BROMO-5-(TRIFLUOROMETHYL)BENZENESULFONYL CHLORIDE is used in the synthesis of sulfonamides and other biologically active compounds. Its participation in organic synthesis reactions is crucial for creating molecules with specific therapeutic or functional properties.
Check Digit Verification of cas no
The CAS Registry Mumber 351003-46-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,5,1,0,0 and 3 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 351003-46:
(8*3)+(7*5)+(6*1)+(5*0)+(4*0)+(3*3)+(2*4)+(1*6)=88
88 % 10 = 8
So 351003-46-8 is a valid CAS Registry Number.
InChI:InChI=1/C7H3BrClF3O2S/c8-5-1-4(7(10,11)12)2-6(3-5)15(9,13)14/h1-3H
351003-46-8Relevant academic research and scientific papers
Design and synthesis of benzenesulfonamide derivatives as potent anti-influenza hemagglutinin inhibitors
Tang, Guozhi,Lin, Xianfeng,Qiu, Zongxing,Li, Wentao,Zhu, Lei,Wang, Lisha,Li, Shaohua,Li, Haodong,Lin, Wenbin,Yang, Mei,Guo, Tao,Chen, Li,Lee, Daniel,Wu, Jim Z.,Yang, Wengang
supporting information; experimental part, p. 603 - 607 (2011/10/09)
Structural optimization of salicylamide-based hemagglutinin (HA) inhibitor 1 resulted in the identification of cis-3-(5-hydroxy-1,3,3- trimethylcyclohexylmethylamino)benzenesulfonamide 28 and its derivatives as potent anti-influenza agents. The lead compo
